SUPPLEMENT
Q1 2021 — Income statement trends
Q1 2021PDF · 2 pages140 KB
CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q119 Q219 Q319 Q419 Q120 Q220 Q320 Q420 Q121 Revenues: Clearing and transaction fees 952.6 1,051.8 1,040.7 901.0 1,278.8 940.2 835.4 843.0 1,007.0 Market data and information services 130.1 128.3 129.8 130.3 131.5 134.7 139.4 139.8 144.2 Other Revenue 96.9 92.6 106.8 107.1 111.8 107.4 105.9 115.7 102.1 Total revenues 1,179.6 1,272.7 1,277.3 1,138.4 1,522.1 1,182.3 1,080.7 1,098.5 1,253.3 Expenses: Compensation and benefits 230.3 227.3 223.5 217.6 207.5 217.0 216.4 215.6 225.0 Technology 47.1 48.6 52.7 53.1 47.7 49.1 48.1 53.6 48.2 Professional fees and outside services 39.4 41.7 43.2 49.8 41.7 51.2 48.4 50.0 37.4 Amortization of purchased intangibles 80.7 76.1 79.8 78.1 77.3 76.6 78.3 79.0 60.6 Depreciation and amortization 32.9 46.3 41.4 38.0 35.3 36.7 39.7 41.5 37.6 Licensing and other fee agreements 40.5 44.8 45.6 41.3 73.9 55.4 57.7 57.9 64.7 Other expense 77.7 89.3 105.9 87.5 78.8 58.8 67.1 85.9 54.7 Operating expenses 548.6 574.1 592.1 565.4 562.2 544.8 555.7 583.5 528.2 Operating Income 631.0 698.6 685.2 573.0 959.9 637.5 525.0 515.0 725.1 Operating Margin 53% 55% 54% 50% 63% 54% 49% 47% 58% Non-operating Income and Expense Investment income 178.7 139.3 172.3 147.6 95.9 32.1 23.6 31.1 30.9 Interest and other borrowing costs (48.1) (45.1) (42.8) (42.0) (40.9) (41.9) (41.7) (41.7) (41.5) Equity in net gains of unconsolidated subsidiaries 40.5 43.8 48.0 44.5 51.2 48.8 44.0 46.6 56.2 Other non-operating income (expense) (161.9) (134.5) (139.5) (99.0) (76.8) (15.2) (14.4) (16.0) (18.4) Non-operating income (expense) 9.2 3.5 38.0 51.1 29.4 23.8 11.5 20.0 27.2 Income before income taxes 640.2 702.1 723.2 624.1 989.3 661.3 536.5 535.0 752.3 Income taxes 144.3 187.5 86.9 155.1 222.5 158.0 125.0 110.2 177.5 Net income 495.9 514.6 636.3 469.0 766.8 503.3 411.5 424.8 574.8 Less: net income (loss) attributable to NCI (1.0) 0.8 - (0.5) 0.6 - (0.2) 0.8 0.4 Net Income Attributable to CME Group 496.9 513.8 636.3 469.5 766.2 503.3 411.7 424.0 574.4 Effective Tax Rate 22.5% 26.7% 12.0% 24.9% 22.5% 23.9% 23.3% 20.6% 23.6% Earnings per Share: Basic EPS 1.39 1.44 1.78 1.31 2.14 1.41 1.15 1.18 1.60 Diluted EPS 1.39 1.43 1.78 1.31 2.14 1.40 1.15 1.18 1.60 Weighted average number of common stock shares: Basic Shares 356,886 357,060 357,211 357,456 357,524 357,691 357,791 358,047 358,147 Diluted Shares 358,047 358,155 358,369 358,354 358,455 358,457 358,590 358,612 358,817 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q119 Q219 Q319 Q419 Q120 Q220 Q320 Q420 Q121 Revenues: Clearing and transaction fees 952.6 1,051.8 1,040.7 901.0 1,278.8 940.2 835.4 843.0 1,007.0 Market data and information services 130.1 128.3 129.8 130.3 131.5 134.7 139.4 139.8 144.2 Other Revenue 96.9 92.6 106.8 107.1 111.8 107.4 105.9 115.7 102.1 Total revenues 1,179.6 1,272.7 1,277.3 1,138.4 1,522.1 1,182.3 1,080.7 1,098.5 1,253.3 Expenses: Compensation and benefits 219.7 218.7 219.2 207.1 210.9 202.7 205.5 202.6 207.5 Technology 47.1 48.1 52.5 51.5 47.3 48.5 47.3 52.2 47.7 Professional fees and outside services 33.7 36.0 37.1 41.4 35.3 42.7 40.0 39.2 27.9 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 32.9 35.7 34.3 35.1 34.5 33.7 37.0 37.2 36.8 Licensing and other fee agreements 40.5 44.8 45.6 41.3 73.9 55.4 57.7 57.9 64.7 Other expense 69.4 67.5 66.4 83.8 57.6 51.9 56.1 74.3 52.1 Operating expenses 443.3 450.8 455.1 460.2 459.5 434.9 443.6 463.4 436.7 Operating Income 736.3 821.9 822.2 678.2 1,062.6 747.4 637.1 635.1 816.6 Operating Margin 62% 65% 64% 60% 70% 63% 59% 58% 65% Non-operating Income and Expense Investment income 176.7 161.0 165.4 126.1 102.3 26.4 22.6 24.1 26.9 Interest and other borrowing costs (48.1) (45.1) (42.8) (42.0) (42.6) (41.9) (41.7) (41.7) (41.5) Equity in net gains of unconsolidated subsidiaries 40.5 43.8 48.0 44.5 51.2 48.8 44.0 46.6 56.2 Other non-operating income (expense) (147.5) (132.2) (138.3) (99.2) (78.3) (15.2) (14.4) (16.0) (18.4) Non-operating income (expense) 21.6 27.5 32.3 29.4 32.6 18.1 10.5 13.0 23.2 Income before income taxes 757.9 849.4 854.5 707.6 1,095.2 765.5 647.6 648.1 839.8 Income taxes 179.7 217.0 175.3 163.7 258.8 182.3 152.8 150.2 198.2 Net income 578.2 632.4 679.2 543.9 836.4 583.2 494.8 497.9 641.6 Less: net income (loss) attributable to NCI (1.0) 0.8 - (0.5) 0.6 - (0.2) 0.8 0.4 Net Income Attributable to CME Group 579.2 631.6 679.2 544.4 835.8 583.2 495.0 497.1 641.2 Effective Tax Rate 23.7% 25.6% 20.5% 23.1% 23.6% 23.8% 23.6% 23.2% 23.6% Earnings per Share: Basic EPS 1.62 1.77 1.90 1.52 2.34 1.63 1.38 1.39 1.79 Diluted EPS 1.62 1.76 1.90 1.52 2.33 1.63 1.38 1.39 1.79 Weighted average number of common stock shares: Basic Shares 356,886 357,060 357,211 357,456 357,524 357,691 357,791 358,047 358,147 Diluted Shares 358,047 358,155 358,369 358,354 358,455 358,457 358,590 358,612 358,817 -- 2 of 2 --